NEPHRIX Biosolutions
PrivateLast Round
Accelerator
Dec 5, 2021
Total Funding Raised
$57,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NEPHRIX Biosolutions is a biotechnology company that provides preclinical contract research services for kidney and fibrotic disease drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NEPHRIX Biosolutions Comparables
Compare NEPHRIX Biosolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Urosphere | 59% | |
| Physiogenex | 57% | |
| Gubra A/S | 51% |
NEPHRIX Biosolutions Funding Rounds
Historical fundraising activity
NEPHRIX Biosolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nubbo | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 54% MoM.
- May 3, 2025
Monthly visitors grew 141% MoM, reaching 1.6K.
NEPHRIX Biosolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NEPHRIX Biosolutions's valuation, stock price, and market status.
Is NEPHRIX Biosolutions a public or private company?
NEPHRIX Biosolutions is a private company.
What is the current stock price of NEPHRIX Biosolutions?
NEPHRIX Biosolutions is a private company, so its shares have no public market price. Caplight tracks NEPHRIX Biosolutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NEPHRIX Biosolutions worth (valuation)?
Valuation information for NEPHRIX Biosolutions is not publicly available.
Can I buy NEPHRIX Biosolutions stock?
NEPHRIX Biosolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NEPHRIX Biosolutions's last funding round?
NEPHRIX Biosolutions's most recent funding round was Accelerator on December 5, 2021.
Who are the main investors in NEPHRIX Biosolutions?
Key investors in NEPHRIX Biosolutions include Nubbo.
Will NEPHRIX Biosolutions IPO soon?
No public IPO plans have been announced for NEPHRIX Biosolutions.
How can I track NEPHRIX Biosolutions secondary market activity?
Caplight tracks bids, offers, and trades in NEPHRIX Biosolutions's shares on secondary markets.